AI for Pharma & Healthcare 2025

Industry Updates

Vital Launches Application Neutral Architecture to Deliver Advanced...

Vital Images, Inc a Minneapolis-based advanced medical imaging and informatics company, is pleased to announce the launch of the latest addition to its enterprise clinical...

Takeda Revises Collaboration Agreement with Amgen to Returns...

Takeda Pharmaceutical Company Limited announced revisions on an existing collaboration agreement, under which Takeda had rights to develop and commercialize multiple molecules / products from...

EC grants marketing authorisation to Odefsey in HIV

Gilead Sciences, Inc announced that the EC hs granted marketing authorization for the once-daily single tablet regimen (STR) Odefsey®(emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25...

Allergan Plc Receives FDA Approval for AVYCAZ sNDA

Allergan plc a leading global pharmaceutical company, announced the U.S. FDA has approved the company's supplemental New Drug Application (sNDA) to update the label for...

St Jude Medical Expands Portfolio with New CRT...

St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies. ...

Key exhibitors and industry partners show strong support...

3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform Established as Asia’s leading exhibition for the medical...

Philips teams up with Visiopharm to boost breast...

Royal Philips announced that it has signed a licensing agreement with Visiopharm to offer their breast cancer panel software algorithms1 with Philips IntelliSite 2 digital...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »